Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BOLT
#4834
Bolt Biotherapeutics, Inc. - Common Stock
3.9
8
USD
+0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.31%
Monthly Change
+2.05%
6 month change
-11.95%
Year Change
-23.02%
Previous Close
3.8
9
Open
3.8
9
Low
3.8
9
High
3.9
8
Volume
7
Markets
US Stock Market
Healthcare
Biotechnology
BOLT
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Q2, 26
Current
Key stats
Total common shares outstanding
1.92 M
1.92 M
1.92 M
1.92 M
1.92 M
1.93 M
1.93 M
Valuation ratios
Enterprise value
6.94 M
1.47 M
-7.54 M
-1.2 M
-3.85 M
-5.44 M
-5.15 M
Price to earnings ratio
-0.24
-0.22
-0.24
-0.31
-0.25
-0.23
-0.24
Price to sales ratio
4.2
2.65
1.96
1.33
1.18
1.55
1.61
Price to cash flow ratio
0.26
0.21
0.22
-0.26
-0.22
-0.22
-0.23
Price to book ratio
0.06
0.05
0.06
0.39
0.06
0.08
0.08
Enterprise value to EBITDA ratio
-0.1
-0.03
0.17
0.03
0.13
0.18
0.17
Profitability ratios
Return on assets %
-0.13
-0.11
-0.11
-0.12
-0.15
-0.19
-0.19
Return on equity %
-0.24
-0.22
-0.22
-0.25
-0.37
-0.61
-0.61
Return on invested capital %
—
—
—
-84.44
—
—
—
Gross margin %
100
100
100
100
100
100
100
Operating margin %
-991.41
-510.53
-355.14
-283.4
-29.23 K
-167.48 K
-167.48 K
EBITDA margin %
-958.76
-491.3
-341.77
-273.2
-28.45 K
-164.06 K
-164.06 K
Net margin %
-903.44
-474.56
-329.37
-265.24
-27.86 K
-154.4 K
-154.4 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
3.13
3.11
3.57
3.59
3.51
2.61
2.61
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0.02
0.03
0.04
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-6.97
-5
-5.07
-3.83
-4.77
-3.87
-17.54
EBIT per share
-6.32
-4.8
-4.01
-3.79
-4.52
-4.95
-17.28
EBITDA per share
-6.11
-4.62
-3.86
-3.65
-4.4
-4.85
-16.77
Total debt per share
—
—
—
—
—
—
—
Cash per share
30.26
25.29
20.21
17.01
14.22
10.71
10.71
Net current asset value per share
22.17
19.99
18.55
16.18
15.32
12.16
12.16
Tangible book value per share
24.42
20.26
16.72
14.17
11.8
7.48
7.48
Working capital per share
15.1
13.57
13.36
11.67
10.95
7.51
7.51
Book value per share
24.42
20.26
16.72
14.17
11.8
7.48
7.48
News
Ryan Breslow is raising up to $27M in pay-to-play bridge funding to save Bolt
Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Misses Revenue Estimates
Oculis Holding AG (OCS) Reports Q2 Loss, Tops Revenue Estimates
Repligen (RGEN) Beats Q2 Earnings and Revenue Estimates
Lightning Labs Announces Wavelength: Offers Developers and AI Agents 'Bitcoin Easy Mode'
Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Lags Revenue Estimates
Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue Estimates
Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue Estimates
Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?
Bolt Biotherapeutics CEO Quinn buys shares worth $686
Nemec, Bolt Biotherapeutics SVP, acquired shares worth $686
Bolt Biotherapeutics stock initiated with Buy rating at H.C. Wainwright